Tobias Fehlmann
- Cancer Research top 0.5%
- MicroRNA in disease regulation 40
- Cancer-related molecular mechanisms research 36
- Molecular Medicine top 2%
- Molecular Biology top 2%
- RNA modifications and cancer 23
- Circular RNAs in diseases 10
- RNA Research and Splicing 9
- Genomics and Phylogenetic Studies 7
- Extracellular vesicles in disease 5
- Gene expression and cancer classification 4
- Neurology top 5%
- Endocrinology top 5%
- Co-authors
- Andreas KellerChristina BackesEckart MeeseNicole LudwigFabian KernValentina GalataHans‐Peter LenhofBenjamin Meder
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (26 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Tobias Fehlmann
77 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 2.3k
- Molecular Medicine 203
- Molecular Biology 2.8k
- Neurology 173
- Endocrinology 101
Countries citing papers authored by Tobias Fehlmann
This map shows the geographic impact of Tobias Fehlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Fehlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Fehlmann more than expected).
Fields of papers citing papers by Tobias Fehlmann
This network shows the impact of papers produced by Tobias Fehlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Fehlmann. The network helps show where Tobias Fehlmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tobias Fehlmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 15 | |
| 3 | 2024 | 0 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 16 | |
| 6 | 2021 | 131 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 44 | |
| 9 | 2020 | 22 | |
| 10 | 2020 | 16 | |
| 11 | 2020 | 139 | |
| 12 | 2020 | 11 | |
| 13 | 2019 | 87 | |
| 14 | 2019 | 12 | |
| 15 | An estimate of the total number of true human miRNAsbreakdown → | 2019 | 403 |
| 16 | 2019 | 59 | |
| 17 | 2019 | 16 | |
| 18 | 2018 | 30 | |
| 19 | 2018 | 108 | |
| 20 | 2017 | 63 |
About Tobias Fehlmann
Tobias Fehlmann is a scholar working on Cancer Research, Molecular Biology and Gender Studies, having authored 79 papers that have together received 4.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (40 papers), Cancer-related molecular mechanisms research (36 papers), RNA modifications and cancer (23 papers), Circular RNAs in diseases (10 papers), RNA Research and Splicing (9 papers), Genomics and Phylogenetic Studies (7 papers), Extracellular vesicles in disease (5 papers) and Gene expression and cancer classification (4 papers). The work is most often cited by research in Cancer Research (2.3k citations), Molecular Medicine (203 citations) and Molecular Biology (2.8k citations). Tobias Fehlmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Andreas Keller, Christina Backes, Eckart Meese, Nicole Ludwig, Fabian Kern, Valentina Galata, Hans‐Peter Lenhof, Benjamin Meder, Petra Leidinger and Tim Kehl. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.